Genmab A/S Sponsored ADR (GMAB) vs Insmed, Inc. (INSM)

Genmab A/S Sponsored ADR and Insmed, Inc. are both Biotechnology companies. Insmed, Inc. is the larger, with a market value of $26.8B against $20.8B — 1.3× the size. Insmed, Inc. has negative trailing earnings, so its P/E is not meaningful; Genmab A/S Sponsored ADR trades at 27.8×. Insmed, Inc. grew revenue faster over the last twelve months: 185.8% against 22.3%. Genmab A/S Sponsored ADR has the higher net margin (19.1% vs −76.9%) and the higher return on invested capital (6.99% vs −329.2%). Across the 19 metrics below, Genmab A/S Sponsored ADR leads on 12 and Insmed, Inc. on 7.